Survival Outcomes and Prognostic Factors in Patients with Metastatic Colorectal Cancer Treated First-Line mFOLFOXIRI Plus Bevacizumab: A Real-World Study in Vietnam
{{output}}
Background: (m)FOLFOXIRI plus bevacizumab has improved outcomes in selected patients with metastatic colorectal cancer (mCRC), but data from Southeast Asia remain limited. This study evaluated survival outcomes and factors associ... ...
